Jacobs selected by Sanofi to deliver new insulin manufacturing facility in Germany

DALLAS–(BUSINESS WIRE)– #OurJacobs–Jacobs selected by Sanofi as the EPCM partner for a new insulin manufacturing facility in Frankfurt, Germany.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.